← Back to All Filings

Vanguard Group Reports 0% Stake in GE HealthCare Following Internal Realignment

Low SignificanceMarch 26, 2026 at 6:39:23 PM EDT

GE HealthCare Technologies Inc.

$GEHCSCHEDULE 13G/ACIK: 0001932393

Subscribe to track GEHC

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

Vanguard Group Reports 0% Stake in GE HealthCare Following Internal Realignment

Company: GE HealthCare Technologies Inc. (CIK: 0001932393) Form: SCHEDULE 13G/A | Filed: 2026/03/26 Significance: Low (Administrative)

Investor: The Vanguard Group Type: Institutional Investor

Filing Details: • Ownership After: 0 shares (0.0%) • Previous Status: Major Holder • Reason: Internal Realignment

Key Insight: The Vanguard Group reports 0% ownership due to an internal corporate realignment. Subsidiaries will now report beneficial ownership separately. This does not necessarily indicate a market sell-off of the underlying shares.

Market Context: Administrative filing adjusting reporting structure for one of the world's largest asset managers.

View Full Filing

Comprehensive Analysis

SEC Filing Analysis: GE HealthCare Technologies Inc.

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: The Vanguard Group reports 0% ownership due to an internal administrative realignment, not a market exit.
  • Market Impact: Neutral; the shares are likely still held by Vanguard subsidiaries which will report separately.

Company Information

FieldValue
CompanyGE HealthCare Technologies Inc.
CIK0001932393
IndustryMedical Devices/Healthcare
Market Cap$31.74 Billion

Insider Information

FieldValue
NameThe Vanguard Group
CIK0000102909
TypeInstitutional Investor (IA)
LocationMalvern, PA

Transaction Details

FieldValue
Form TypeSCHEDULE 13G/A
Event Date03/13/2026
Shares Owned After0
Ownership %0.0%
Voting Power0

Financial Impact Assessment

Transaction Materiality

MetricValue
Post-Transaction Ownership0 shares (0% of outstanding)
Materiality AssessmentLow (Administrative Nature)

Impact Evaluation

  • Market Cap Context: While Vanguard is a massive holder, this specific filing represents a change in reporting structure, not necessarily a change in investment conviction.
  • Ownership Concentration: The filing explicitly states that subsidiaries or business divisions will now report beneficial ownership separately on a disaggregated basis.
  • Transaction Significance: The reduction to 0% is technical. The filing notes: "The Vanguard Group, Inc. no longer has, or is deemed to have, beneficial ownership over securities beneficially owned by such subsidiaries."

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: This is a compliance and legal restructuring of how Vanguard reports holdings to the SEC. It does not reflect a bearish sentiment or a liquidation of the position.

Volume & Sentiment

  • Expected Volume Impact: Negligible.
  • Sentiment Indicator: Neutral.

Additional Context

Transaction Notes

  • Realignment Details: On January 12, 2026, Vanguard underwent an internal realignment. In accordance with SEC Release No. 34-39538, subsidiaries will report separately.
  • Regulatory Note: This filing effectively closes the reporting obligation for the parent entity "The Vanguard Group" regarding these specific shares, shifting the reporting burden to its subsidiaries.
Topics:#SECFiling#GEHealthCare#Vanguard#InstitutionalInvestor#Form13G#StockMarket#FinancialAnalysis#RegulatoryFiling

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.